infections, respiratory tract

Showing 1 - 17 of 17

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Otitis Media, Infections, Respiratory Tract, Respiratory Tract Infections Trial in India (Augmentin (ES)-600)

Completed
  • Otitis Media
  • +2 more
  • Augmentin (ES)-600
  • Raipur, Chhattisgarh, India
  • +12 more
Nov 30, 2022

Infections, Respiratory Tract Trial in Erfurt (FluimucilĀ® 2% solution, Acetylcysteine 2% solution)

Completed
  • Infections, Respiratory Tract
  • FluimucilĀ® 2% solution
  • Acetylcysteine 2% solution
  • Erfurt, Thueringen, Germany
    GSK Investigational Site
Jan 23, 2019

Infections, Respiratory Tract Trial (Paracetamol, phenylephrine HCl, pheniramine maleate, and vitamin C)

Withdrawn
  • Infections, Respiratory Tract
  • Paracetamol, phenylephrine HCl, pheniramine maleate, and vitamin C
  • (no location specified)
Mar 9, 2018

Infections, Respiratory Tract Trial (Paracetamol, phenylephrine HCl, and vitamin C)

Withdrawn
  • Infections, Respiratory Tract
  • Paracetamol, phenylephrine HCl, and vitamin C
  • (no location specified)
Mar 9, 2018

Infections, Respiratory Tract Trial (400 mg Amoxicillin + 57 mg Clavulanic Acid/ 5 ml)

Completed
  • Infections, Respiratory Tract
  • 400 mg Amoxicillin + 57 mg Clavulanic Acid/ 5 ml
  • (no location specified)
Aug 2, 2017

Infections, Respiratory Tract Trial in United States (amoxicillin/clavulanate potassium)

Completed
  • Infections, Respiratory Tract
  • amoxicillin/clavulanate potassium
  • Little Rock, Arkansas
  • +5 more
Jul 31, 2017

Infections, Respiratory Tract Trial in London (GSK2140944 for Injection, GSK2140944 Capsule)

Completed
  • Infections, Respiratory Tract
  • GSK2140944 for Injection
  • GSK2140944 Capsule
  • London, United Kingdom
    GSK Investigational Site
Jul 10, 2017

Infections, Respiratory Tract Trial in Austin (GSK2140944, GSK2140944 , Moxifloxacin)

Completed
  • Infections, Respiratory Tract
  • Austin, Texas
    GSK Investigational Site
Jul 10, 2017

Infections, Respiratory Tract Trial (Cephalexin 1g tablets)

Completed
  • Infections, Respiratory Tract
  • Cephalexin 1g tablets
  • (no location specified)
Jul 5, 2017

Infections, Respiratory Tract Trial (Cephalexin 125 mg/5ml)

Completed
  • Infections, Respiratory Tract
  • Cephalexin 125 mg/5ml
  • (no location specified)
Jun 21, 2017

Infections, Respiratory Tract Trial in Minneapolis (GSK2140944, Placebo)

Completed
  • Infections, Respiratory Tract
  • Minneapolis, Minnesota
    GSK Investigational Site
Jun 9, 2017

Infections, Respiratory Tract Trial (Cephalexin 125 mg/5ml, Cephalexin 250mg/5ml)

Completed
  • Infections, Respiratory Tract
  • Cephalexin 125 mg/5ml
  • Cephalexin 250mg/5ml
  • (no location specified)
Jun 2, 2017

Infections, Respiratory Tract Trial in Overland Park (GSK1325756 Solution, GSK1325756 Solution Matching Placebo, GSK1325756

Completed
  • Infections, Respiratory Tract
  • GSK1325756 Solution
  • +3 more
  • Overland Park, Kansas
    GSK Investigational Site
May 12, 2017

Infections, Respiratory Tract Trial in Overland Park (GSK2140944, Placebo)

Completed
  • Infections, Respiratory Tract
  • Overland Park, Kansas
    GSK Investigational Site
May 5, 2017

Infections, Respiratory Tract Trial in Randwick (Part A: GSK2140944 Drug single dose of 200mg, 600mg, 1200mg, 1800 mg, and dose

Completed
  • Infections, Respiratory Tract
  • Part A: GSK2140944 Drug single dose of 200mg, 600mg, 1200mg, 1800 mg, and dose to be determined
  • Part B: GSK2140944 Repeat Drug dose of 400mg, 750mg, 1000 mg, and dose to be determined
  • Randwick, New South Wales, Australia
    GSK Investigational Site
May 5, 2017

Program Retrospective Chart Review Study

Completed
  • Infections, Respiratory Tract
  • retrospective chart review
  • (no location specified)
Nov 21, 2016

Infections, Respiratory Tract Trial in Lviv (L. acidophilus DDS-1, B. lactis UABLA-12, Placebo)

Completed
  • Infections, Respiratory Tract
  • L. acidophilus DDS-1, B. lactis UABLA-12
  • Placebo
  • Lviv, Ukraine
    Lviv City Children Hospital
Dec 25, 2013